SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-027572
Filing Date
2018-10-29
Accepted
2018-10-29 16:00:32
Documents
2
Period of Report
2018-10-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1563
2 EX-24 DOCUMENT attachment1.htm EX-24 3025
  Complete submission text file 0000899243-18-027572.txt   6132
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Issuer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 3826 Laboratory Analytical Instruments

Mailing Address 1700 KENT AVENUE WEST LAFAYETTE IN 46906
Business Address
Landis John B. (Reporting) CIK: 0001477283 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51122 | Film No.: 181144214